(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 5.96%-7.85M | -86.78%-10.92M | 6.51%-11.27M | 0.25%-27.09M | 88.19%-834.2K | -30.37%-8.35M | 33.80%-5.85M | -148.49%-12.05M | -574.31%-27.16M | -239.24%-7.06M |
Net income from continuing operations | -133.46%-9.85M | 22.02%-7.58M | -30.18%-19.74M | -16.36%-37.72M | -7.41%-8.61M | 30.49%-4.22M | -0.71%-9.72M | -74.81%-15.17M | -494.04%-32.42M | -235.61%-8.02M |
Operating gains losses | -130.54%-26.25K | -6.91%-3.99K | 198.92%50.45K | 151.53%18.43K | 81.08%-12.81K | 237.18%85.97K | -130.82%-3.73K | -802.39%-51K | -25.58%-35.76K | 7.84%-67.71K |
Depreciation and amortization | 282.09%15.21K | 334.66%13.43K | 178.73%7.33K | 40.37%17.23K | 104.70%7.53K | 10.37%3.98K | 12.28%3.09K | 17.48%2.63K | 39.31%12.28K | 44.09%3.68K |
Asset impairment expenditure | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --73.14K | ---- |
Remuneration paid in stock | 69.13%4.62M | 22.91%758.61K | 58.16%895.55K | 59.57%4.67M | 4.53%758.51K | 89.24%2.73M | 62.53%617.19K | 49.10%566.24K | 409.92%2.93M | 358.52%725.65K |
Other non cashItems | -62.06%121.11K | 246.35%842.37K | 650.45%1.67M | 94.78%797.3K | -95.55%11.84K | 1,601.47%319.21K | 228.52%243.21K | 342.44%223.04K | 49.69%409.34K | 47.51%266.14K |
Change In working capital | 62.42%-2.73M | -264.62%-4.96M | 146.39%5.85M | 173.80%5.13M | 15,666.79%7.01M | -297.78%-7.27M | 769.71%3.01M | -30.17%2.37M | 211.24%1.87M | -213.91%-45.06K |
-Change in receivables | -35.86%-1.58M | -70.05%1.74M | 83.06%-617.83K | 166.66%2.11M | 131.02%1.11M | -538.72%-1.16M | 2,970.12%5.81M | -7,464.54%-3.65M | -254.00%-3.16M | -590.36%-3.56M |
-Change in payables and accrued expense | 81.08%-1.16M | -139.32%-6.7M | 7.40%6.47M | -39.97%3.02M | 67.90%5.91M | -192.06%-6.11M | -1,882.40%-2.8M | 74.64%6.02M | 236.78%5.03M | 533.12%3.52M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 5.96%-7.85M | -86.78%-10.92M | 6.51%-11.27M | 0.25%-27.09M | 88.19%-834.2K | -30.37%-8.35M | 33.80%-5.85M | -148.49%-12.05M | -574.31%-27.16M | -239.24%-7.06M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 135.99%5.4M | 2.31M | 3,832.07%5M | -12,040.19%-15.32M | -189.42K | -15M | 0 | -6.10%-133.92K | -0.37%-126.22K | 0 |
Capital expenditure reported | --0 | ---2.14M | -0.86%-135.08K | -6.10%-133.92K | --0 | --0 | --0 | -6.10%-133.92K | -0.37%-126.22K | --0 |
Net PPE purchase and sale | --118K | ---- | ---- | ---189.42K | ---189.42K | --0 | ---- | ---- | --0 | ---- |
Net investment purchase and sale | 135.21%5.28M | --5.2M | --5.13M | ---15M | --0 | ---15M | --0 | --0 | --0 | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 135.99%5.4M | --2.31M | 3,832.07%5M | -12,040.19%-15.32M | ---189.42K | ---15M | --0 | -6.10%-133.92K | -0.37%-126.22K | --0 |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -98.88%936.96K | 252.41%1.25M | 2,471.57%361.69K | 183.91%84.71M | -97.84%635.74K | 125,282.75%83.7M | 269.01%354.7K | -93.04%14.07K | 22.49%29.83M | 35.51%29.47M |
Net issuance payments of debt | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -58.39%11.05K | ---- |
Net common stock issuance | ---- | ---- | ---- | 185.53%85.66M | --0 | ---- | ---- | ---- | 20.00%30M | --30M |
Proceeds from stock option exercised by employees | 92.94%950.37K | 243.87%1.26M | 1,279.03%375.1K | 208.14%1.53M | 504.01%640.65K | 554.33%492.58K | 252.23%367.46K | -87.06%27.2K | 751.60%495.85K | 82.17%106.07K |
Net other financing activities | 99.45%-13.41K | -6.38%-13.57K | -2.05%-13.4K | -269.46%-2.48M | 99.24%-4.91K | -28,666.60%-2.45M | -55.54%-12.76K | -61.40%-13.14K | 7.66%-672.03K | 8.44%-647.17K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -98.88%936.96K | 252.41%1.25M | 2,471.57%361.69K | 183.91%84.71M | -97.84%635.74K | 125,282.75%83.7M | 269.01%354.7K | -93.04%14.07K | 22.49%29.83M | 35.51%29.47M |
Net cash flow | ||||||||||
Beginning cash position | 822.33%45.67M | 383.33%53.24M | 155.93%59.5M | 10.71%23.25M | 10,255.72%66.05M | -27.55%4.95M | -31.04%11.01M | 10.71%23.25M | 2,236.41%21M | -54.00%637.81K |
Current changes in cash | -102.52%-1.52M | -34.04%-7.36M | 51.46%-5.91M | 1,557.30%42.29M | -101.73%-387.88K | 1,051.87%60.35M | 37.13%-5.49M | -154.95%-12.17M | -87.37%2.55M | 13.99%22.41M |
Effect of exchange rate changes | -109.84%-73.87K | 65.03%-198.74K | -471.23%-359.03K | -1,895.09%-6.04M | -3,094.46%-6.16M | 425.47%750.29K | -43.03%-568.34K | 75.24%-62.85K | -194.91%-302.77K | 580.23%205.7K |
End cash Position | -33.26%44.08M | 822.33%45.67M | 383.33%53.24M | 155.93%59.5M | 155.93%59.5M | 10,255.72%66.05M | -27.55%4.95M | -31.04%11.01M | 10.71%23.25M | 10.71%23.25M |
Free cash from | 7.38%-7.74M | -136.26%-13.82M | 6.43%-11.4M | -0.47%-27.41M | 85.51%-1.02M | -30.37%-8.35M | 33.80%-5.85M | -144.88%-12.19M | -556.93%-27.28M | -237.86%-7.06M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data